CME Unit: 1 Point
Submission Deadline*: 17 Nov 2023
IgA nephropathy (IgAN) is the most common type of glomerulonephritis worldwide. The disease is a progressive inflammatory kidney disease that requires long-term treatment to reduce the risk of progression to kidney failure1. Nonetheless, 20% to 40% of patients with IgAN eventually develop end-stage kidney disease (ESKD) within 25 years, and kidney transplantation remains one of the prime therapeutic options in these individuals. Essentially, recurrence of IgAN post renal transplant can occur with a frequency ranging from 20% to 60%2. There is currently no specific treatment option available for recurrent IgAN, so strategies for improving graft survival are crucial. The aim of this article is to discuss the pathophysiology and management of IgAN. Essentially, preventive strategies addressed in existing literature for recurrent IgAN, and prolonging survival of kidney graft will be reviewed.
This CME article was prepared by Dr. Mohsin Roshan and Dr. Roy Yuen-chi Lau and accredited by the Hong Kong Doctors Union (HKDU).
*Submissions after 17 Nov 2023 will not be accepted.
IgA nephropathy (IgAN) is the most common type of glomerulonephritis worldwide. The disease is a progressive inflammatory kidney disease that requires long-term treatment to reduce the risk of progression to kidney failure 1 . Nonetheless, 20% to 40...
The Burden of Chronic Kidney Disease Chronic kidney disease (CKD) is one of the most prominent causes of death and suffering in the 21 st century. The number of patients affected by CKD has substantially increased with an estimate of 843.6 million i...
Chronic kidney disease (CKD) is an increasing public health concern with an estimated global prevalence of 10.6% for stages 3-5 and 13.4% for stages 1-5. In 2016, there were 275.9 million cases of CKD with around 1.2 million deaths and 35 million ye...
Kerendia ® ( Finerenone ) 4 Bayer Finerenone is a nonsteroidal mineralocorticoid receptor (MR) antagonist Compositio n : Available as 10mg and 20mg oral tablets Indications : Newly indicated for delaying progressive decline of kidney function ...
Triplixam ® ( perindopril arginine/indapamide/amlodipine ) 5 Servier Perindopril is an angiotensin converting enzyme inhibitor (ACE inhibitor) Indapamide is a thiazide diuretic Amlodipine is a calcium-channel blocker (CCB) Compositio n : Availa...
Autoimmune disorders, such as rheumatoid arthritis, psoriasis, systemic sclerosis, lupus erythematosus, and type 1 diabetes, were found to be linked with increased CV risks, with risk dependent on the types of autoimmune disorders. In a population-b...
“Adequate” to “High-quality Goal-directed” In healthcare settings, the delivery of PD primarily focuses on small solute removal and ultrafiltration as highlighted by the International Society for Peritoneal Dialysis (ISPD) gu...
Kidney Health Education for All - A Snapshot on Current Scenario and Action Strategies The Clinical Importance of Health Literacy CKD patients have to make day-to-day decisions about how to self-manage their conditions, including their diet and work...
The first season of the “Kidneys Talk”, a live channel organised by the Hong Kong Kidney Foundation (HKKF), with the Hong Kong Society of Nephrology (HKSN) and the Hong Kong Association of Renal Nurses (HKARN) as the co-organisers, has b...
Early Blood Glucose Control as the Key to Preventing and Delaying Progression DM is the leading cause of CKD worldwide. The Hong Kong Central Renal Registry reported that diabetic nephropathy (DN) accounts for nearly 50% of patients who undergo dial...
Local Burden of CKD Although a CKD registry is currently not available in Hong Kong, the CKD burden can be reflected by the ESRD burden captured by the Hong Kong Renal Registry, which is a systematic online system developed in 1995 by the Hospital A...
